🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareGLP-1 receptor agonists and thyroid C-cell concerns — what worked for you? Page 3

GLP-1 receptor agonists and thyroid C-cell concerns — what worked for you?

pam_columbus Sun, Dec 21, 2025 at 7:19 PM 11 replies 1,075 viewsPage 3 of 3
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Dec 24, 2025 at 5:41 PM#11
Dr.SportsMedIN said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.

Correct me if the detail matters more than I have assumed.

6 6Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 3 others
Reply Quote Save Share Report
fiona_VT
Member
178
890
Dec 2024
Vermont
Dec 26, 2025 at 4:43 PM#12
HPLC_Greg said:
Agreed, and the adaptation point cuts both ways: tachyphylaxis to gastric emptying is why tolerability improves, and it is also why people who were…

Saving this. It is the first explanation that did not require me to already understand it.

5 5hans_munich, jason_sac26, chris_chi24 and 2 others
Reply Quote Save Share Report
pete_manc_UK
Senior Member
1,234
5,678
Mar 2024
Manchester, UK
Dec 28, 2025 at 3:44 PM#13
Dr.SportsMedIN said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

This is where I part company with the consensus forming above. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

Last edited: Dec 28, 2025 at 9:44 PM
4 4FitDadDave, RunnerRach, TrialNerd_Beth and 1 other
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Dec 30, 2025 at 2:44 PM#14

One concrete data point for the thread. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

Last edited: Dec 30, 2025 at 7:44 PM
3 3Dr.PulmRoch, maya_sedona, stefan_berlin
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jan 1, 2026 at 1:43 PM#15

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here.

2 2PeptideSynthNJ, Dr.KarenChen
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register